Navigation Links
Inflamax Research Appoints ,Dr. Anne Marie Salapatek President & Chief Scientific Officer
Date:2/18/2013

Toronto, Ontario (PRWEB) February 18, 2013

Dr. Salapatek is an internationally renowned scientist with expertise in allergy, asthma and EEC clinical trials. Previously she was the Principal Scientist at Cetero Research (formerly Allied Research International) where she was responsible for the development and validation of new Allergy and Asthma clinical models, advising clients on study designs including utilizing EEC technology for seasonal and perennial allergies, asthma, non-allergic rhinoconjunctivitis and COPD. Dr. Salapatek has worked with many clients to realize their drug development program goals by providing expert study design, regulatory strategy, and data analysis and interpretation. Dr Salapatek has presented her research at numerous international meetings including the FDA workshops and Advisory Panels on the utility of Environmental Exposure Chambers in pivotal, Phase 3 studies.

“I have worked with Anne Marie before and I am delighted that she has joined us at Inflamax Research, where her extensive experience in Environmental Exposure Chambers and drug development will prove invaluable to our clients,“ said Dr. Piyush Patel, Inflamax’s CEO. “Dr. Salapatek has close working relationships with numerous key opinion leaders and scientists in the pharmaceutical industry, as well, she has a proven track record in designing and overseeing complex Phase 1 to 4 clinical trials She brings a high caliber of scientific credibility, rigor and integrity which is at the core of Inflamax’s approach to clinical research. With the addition of Dr. Salapatek’s expertise to our science team, Inflamax now has unparalleled capability to design and perform complex large and small clinical trials using EEC technology."

“I am excited to join Inflamax Research and look forward to helping to lead and shape a company that has as its core tenet: “Scientific Excellence in Clinical Research”.” said Dr. Salapatek. “
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Inflamax Research announces the launch of its Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials
2. Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
3. Wolters Kluwer Research Now Available via Bloomberg Tradebook
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
6. Researching graphene nanoelectronics for a post-silicon world
7. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
8. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
9. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
10. Multidisciplinary team of researchers develop world’s lightest material
11. K computer research results awarded ACM Gordon Bell Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... LONDON, Sept. 30, 2014 This ... Enzymes in US$ Million by the following ... Specialty Enzymes. Specific end-use segments also analyzed ... The report provides separate comprehensive ... Asia-Pacific, Middle East, and Latin America. Annual ...
(Date:9/30/2014)... 2014 Applying a well-known optical phenomenon called ... University has demonstrated the ability to "paint" ultra-thin ... holds promise for making future, flexible electronic devices, ... of next-gen rocket ships and spacecraft with extremely ... oil in water, it becomes iridescent, revealing a ...
(Date:9/30/2014)... Sept. 30, 2014 Pacific Northwest Biotechnology, ... Summary Global Markets Direct,s, ,Pacific Northwest Biotechnology, ... an overview of the Pacific Northwest Biotechnology, LLC,s ... provides comprehensive information on the current therapeutic developmental ... comparative analysis at various stages, therapeutics assessment by ...
(Date:9/30/2014)... Sept. 30, 2014 Nematicide is a ... Nematodes are microscopic parasitic roundworms, found in massive ... other plants and animals. Nematicides have tended to ... properties promoting migration through the soil. A single ... plant-parasitic nematodes. With more than 10,000 species classified, ...
Breaking Biology Technology:Global Specialty Enzymes Industry 2Global Specialty Enzymes Industry 3Global Specialty Enzymes Industry 4Global Specialty Enzymes Industry 5Global Specialty Enzymes Industry 6Global Specialty Enzymes Industry 7Global Specialty Enzymes Industry 8Global Specialty Enzymes Industry 9Global Specialty Enzymes Industry 10Global Specialty Enzymes Industry 11Global Specialty Enzymes Industry 12Global Specialty Enzymes Industry 13Global Specialty Enzymes Industry 14Global Specialty Enzymes Industry 15Global Specialty Enzymes Industry 16Global Specialty Enzymes Industry 17Global Specialty Enzymes Industry 18Global Specialty Enzymes Industry 19Global Specialty Enzymes Industry 20Global Specialty Enzymes Industry 21Global Specialty Enzymes Industry 22Global Specialty Enzymes Industry 23Global Specialty Enzymes Industry 24Global Specialty Enzymes Industry 25Global Specialty Enzymes Industry 26Taking thin films to the extreme 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Nematicides Market by Types (Fumigants, Organophosphates, Carbamate and Bio-Nematicides), Applications (Agrochemicals, Industrial, and Others), and Geography (North America, Europe, Asia-Pacific & ROW) - Global Trends & Forecasts to 2019 2
... - Company to be Featured on Oct 25, ... VIA Pharmaceuticals,(Nasdaq: VIAP ) a biotechnology company ... of cardiovascular disease, announced today that,Windhover Information has ... the top ten most interesting cardiovascular projects available ...
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI ... and,medical device company, today announced preliminary financial ... 2007 and updated its financial,outlook for the ... conjunction with the,release of Boston Scientific Corporation,s ...
... Fla., Oct. 19 An affiliate of,Phlo ... today that,the distribution of its vitality product, ... system-wide coverage within Northern California and has,been ... the,Palm Desert/Palm Springs area. In Northern ...
Cached Biology Technology:VIA Pharmaceuticals' Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Information's Therapeutic Area Partnerships Conference 2VIA Pharmaceuticals' Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Information's Therapeutic Area Partnerships Conference 3VIA Pharmaceuticals' Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Information's Therapeutic Area Partnerships Conference 4Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 3Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 4Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 5Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 6Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 7Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 8Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 9Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 10Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 11AQUISS Continues Expansion Into New Territory 2
(Date:10/1/2014)... take a healthy salad up a level by growing ... in leafy greens. , "In the long run, one ... the salad or making a pill from the plant ... at Case Western Reserve School of Medicine and leader ... cancer organization is funding the research with a three-year, ...
(Date:10/1/2014)... 1, 2014 Novel detection ... science field  The life science field ... over the years. Some are shooting stars and ... a novel detection technology that has raised much ... this technology is becoming commercially available. With their ...
(Date:9/30/2014)... tourists visit the Mediterranean each year, but its ... on Earth. Almost 1,000 alien species, including fish, ... seas through human activities. In the open-access journal ... team of researchers analyzed data from a new ... show how the introduction of alien species has ...
Breaking Biology News(10 mins):Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3First-of-a-kind Solution for Utilizing Photon Upconversion 2Biodiversity in the Mediterranean is threatened by alien species 2
... Chestnut due to an Asian bark fungus accidentally introduced to ... the tree was highly valued for its strong, workable lumber ... bears relied upon the chestnut for food. Ongoing efforts ... in part because they rely on genetic cross breeding ...
... Each year, millions of monarch butterflies ( Danaus plexippus ... colonize eastern North America, but just how these delicate ... breeding range in spring has largely remained a mystery. ... led by Prof. Ryan Norris, Department of Integrative Biology, ...
... -- Findings from a first-of-its-kind study by Indiana University ... or fantasies -- can lead to female orgasm. ... phenomenon, sometimes called "coregasm" because of its association with ... media for years, said Debby Herbenick, co-director of the ...
Cached Biology News:UC research tests new tool to guide reintroduction of the American chestnut 2UC research tests new tool to guide reintroduction of the American chestnut 3Study reveals how monarch butterflies recolonize northern breeding range 2Study: Exercise can lead to female orgasm, sexual pleasure 2Study: Exercise can lead to female orgasm, sexual pleasure 3
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
... 3 (MUC3) is a glycoprotein. distributed ... lesser extent in breast, lung and salivary ... no cross-reaction with MUC1 and MUC2. ... MUC3 Immunogen: MUC3 tandem repeat ...
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
Biology Products: